Search

Search Constraints

You searched for: Author/Creator Barone, Francesca

Search Results

1. 04.23 Identification of a novel subset of pathogenic stromal cells with key effector functions in tissue inflammation and damage. (1st March 2017)

2. A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome. (19th September 2020)

4. AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME (PSS). (June 2019)

8. Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study. (March 2020)

10. B-cell activity markers are associated with different disease activity domains in primary Sjögren's syndrome. (28th March 2018)